BIO-key International, Inc.
BKYIIndustrialsNASDAQSecurity & Protection Services · Last scanned Sep 9, 2026
Scan Results
Daily timeframeBIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally. At a $3.8M market cap, BIO-key International, Inc. ranks as a micro-cap company within industrials. It offers BIO-key PortalGuard and PortalGuard IDaaS cloud-based identity platforms, which allows authentication through an IAM platform; and BIO-key VST and WEB-key; civil and large-scale ID infrastructure.
Market Cap
$3.8M
Beta
0.40
P/E (TTM)
—
P/E (Fwd)
12.14
EPS (TTM)
$-8.20
EPS (Fwd)
$0.22
ROE
-107.9%
ROA
-22.9%
Cash
$1.4M
Total Debt
$861,852
Free CF
-$2.7M
52W Change
-63.0%
Annual Financials
Cash vs Debt
Where BKYI stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, BKYI finished 41.98% below its 150-day moving average ($5.05) and 46.82% below its 200-day moving average ($5.51). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is BKYI overbought or oversold?
At the September 3, 2026 close, BKYI's RSI(14) was 20.4, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
BIO-key International, Inc. holds $1.4M in cash against $862K in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company is burning cash, with free cash flow at -$2.7M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -107.9% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $7.0M (2022) to $5.9M (2025), a 15% decline worth watching.
BKYI's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. No single metric tells the full story. Reviewing BKYI's risk profile alongside its fundamentals and technical indicators provides a more complete picture.